Claudia Maria Bertan Membrive

Claudia Maria Bertan Membrive

Auto-generated profile, based on publicly available information

Claudia Maria Bertan Membrive

The Institute of Cancer Research, Sutton, United Kingdom

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Theriogenology
Verified
Journal Article
Closed access
FMFernando Silveira Mesquita
Fernando Silveira Mesquita
GPG. Pugliesi
G. Pugliesi
SSS.C. Scolari
S.C. Scolari
MFM.R. França
M.R. França
RRR.S. Ramos
R.S. Ramos
MBM. Binelli
M. Binelli

1 August 2015 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
FMFernando Silveira Mesquita
Fernando Silveira Mesquita
RRR. S. Ramos
R. S. Ramos
GPG. Pugliesi
G. Pugliesi
SASónia Cristina Da Silva Andrade
Sónia Cristina Da Silva Andrade
VHV. Van Hoeck
V. Van Hoeck
MBMario Binelli
Mario Binelli
This study aimed to characterize the endometrial transcriptome and functional pathways overrepresented in the endometrium of cows treated to ovulate larger (≥ 13 mm) versus smaller (≤ 12 mm) follicles. Nelore cows were pre-synchronized prior to receiving cloprostenol (large follicle; LF) or not (small follicle group; SF), along with a progesterone device on D−10. Devices were withdrawn and cloprostenol administered 42 to 60 hours (LF) or 30 to 36 hours (SF) before GnRH agonist treatment (D0). Tissues were collected on D4 (Exp.1; N = 24) or D7 (Exp.2; N = 60). Endometrial transcriptome was obtained by RNA-seq whereas proliferation and apoptosis were assessed by immunohistochemistry. Overall, LF cows developed larger follicles and CLs, and produced greater amounts of E2 (D-1; Exp.1; SF: 0.7±0.2; LF: 2.4±0.2 pg/mL; Exp.2; SF: 0.5±0.1; LF: 2.3±0.6 pg/mL) and P4 (D4; Exp.1; SF: 0.8±0.1; LF: 1.4±0.2 ng/mL; D7; Exp.2; SF: 2.5±0.4; LF: 3.7±0.4 ng/mL). Functional enrichment indicated that biosynthetic and metabolic processes were enriched in LF endometrium, whereas SF endometrium transcriptome was biased towards cell proliferation. Data also suggested reorganization of the extracellular matrix (ECM) towards a proliferation permissive phenotype in SF endometrium. LF endometrium showed an earlier onset of proliferative activity, whereas SF endometrium expressed a delayed increase in glandular epithelium proliferation. In conclusion, the periovulatory endocrine milieu regulates bovine endometrial transcriptome and seems to determine the transition from a proliferation permissive to a biosynthetic and metabolically active endometrial phenotype, which may be associated with the preparation of an optimally receptive uterine environment.

1 October 2006 in Theriogenology
Verified
Journal Article
Closed access
MLMarcelo Rezende Luz
Marcelo Rezende Luz
CBClaudia Maria Bertan
Claudia Maria Bertan
MBMario Binelli
Mario Binelli
MLMaria Denise Lopes
Maria Denise Lopes

2 February 2018 in Biology
Verified
Journal Article
Open access
PDF file
MBMario Binelli
Mario Binelli
Angela Gonella-DiazaAngela Gonella-Diaza
Angela Gonella-Diaza
FMFernando Silveira Mesquita
Fernando Silveira Mesquita
CMClaudia Maria Bertan Membrive
Claudia Maria Bertan Membrive
In cattle, the oviduct is a tubular organ that connects the ovary and the uterus. The oviduct lumen stages a dynamic set of cellular and molecular interactions to fulfill the noble role of generating a new individual. Specific anatomical niches along the oviduct lumen provide the appropriate microenvironment for final sperm capacitation, oocyte capture and fertilization, and early embryo development and transport. To accomplish such complex tasks, the oviduct undergoes spatially and temporally-regulated morphological, biochemical, and physiological changes that are associated with endocrine events of the estrous cycle. Specifically, elevated periovulatory concentrations of estradiol (E2) and progesterone (P4) influence gene expression and morphological changes that have been associated positively to fertility in beef cattle. In this review, we explore how E2 and P4 influence oviductal function in the beginning of the estrous cycle, and prepare the oviductal lumen for interactions with gametes and embryos.

12 October 2017 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GSGeorge Seed
George Seed
WYWei Yuan
Wei Yuan
JMJoaquin Mateo
Joaquin Mateo
SCSuzanne Carreira
Suzanne Carreira
CBClaudia Bertan
Claudia Bertan
JBJohann S. de Bono
Johann S. de Bono
Purpose: Precise detection of copy number aberrations (CNA) from tumor biopsies is critically important to the treatment of metastatic prostate cancer. The use of targeted panel next-generation sequencing (NGS) is inexpensive, high throughput, and easily feasible, allowing single-nucleotide variant calls, but CNA estimation from this remains challenging. Experimental Design: We evaluated CNVkit for CNA identification from amplicon-based targeted NGS in a cohort of 110 fresh castration-resistant prostate cancer biopsies and used capture-based whole-exome sequencing (WES), array comparative genomic hybridization (aCGH), and FISH to explore the viability of this approach. Results: We showed that this method produced highly reproducible CNA results (r = 0.92), with the use of pooled germline DNA as a coverage reference supporting precise CNA estimation. CNA estimates from targeted NGS were comparable with WES (r = 0.86) and aCGH (r = 0.7); for key selected genes (BRCA2, MYC, PIK3CA, PTEN, and RB1), CNA estimation correlated well with WES (r = 0.91) and aCGH (r = 0.84) results. The frequency of CNAs in our population was comparable with that previously described (i.e., deep deletions: BRCA2 4.5%; RB1 8.2%; PTEN 15.5%; amplification: AR 45.5%; gain: MYC 31.8%). We also showed, utilizing FISH, that CNA estimation can be impacted by intratumor heterogeneity and demonstrated that tumor microdissection allows NGS to provide more precise CNA estimates. Conclusions: Targeted NGS and CNVkit-based analyses provide a robust, precise, high-throughput, and cost-effective method for CNA estimation for the delivery of more precise patient care. Clin Cancer Res; 23(20); 6070–7. ©2017 AACR.

23 September 2016
Verified
Book Chapter
Closed access
PDF file
CMClaudia Maria Bertan Membrive
Claudia Maria Bertan Membrive